13,14-DIHYDRO-13-OXAPROSTAGLANDIN-F2ALPHA METHYL ESTER, TRIACETATE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | E1kiIaQ8ah2 |
|---|---|
| InChI | InChI=1S/C26H42O9/c1-6-7-10-13-21(33-18(2)27)17-32-26-22(14-11-8-9-12-15-25(30)31-5)23(34-19(3)28)16-24(26)35-20(4)29/h8,11,21-24,26H,6-7,9-10,12-17H2,1-5H3/b11-8-/t21-,22-,23-,24+,26+/m1/s1 |
| InChIKey | NCJUWBJSFWBQCA-KGVXAIAYSA-N |
| Mol Weight | 498.6 g/mol |
| Molecular Formula | C26H42O9 |
| Exact Mass | 498.282883 g/mol |
| Enantiomer InChIKey | NCJUWBJSFWBQCA-XSZRLRLUSA-N |
| Copyright | Copyright © 2002-2024 Wiley-VCH Verlag GmbH & Co. KGaA. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 chloroform-d |
(+/-)-1ALPHA-[6-METHOXYCARBONYLHEX-2Z-ENYL]-2BETA-TRIPHENYLMETHOXYMETHYL-3ALPHA,5ALPHA-DIACETOXYCYCLOPENTANE
9,11,15-TRIACETOXY-PROSTAGLANDIN PGF2 ALPHA
2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-butenyl]hexahydro-, [3aR-[3a.alpha.,4.alpha.(E),5.beta.,6a.alpha.]]-
2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)hexahydro-4-(4-hydroxy-2-butenyl)-, [3aR-[3a.alpha.,4.alpha.(E),5.beta.,6a.alpha.]]-
5-exo,9-endo-Diacetoxy-7-oxabicyclo[4.3.0]nonane-8-one
Prost-13-en-1-oic acid, 9,11-bis(acetyloxy)-15-hydroxy-, methyl ester, (9.beta.,11.alpha.,13E,15S)-
6,7-(PROPANE-2-DIHYDROXY)-2-OXABICYCLO[3.3.0]OCTAN-3-ONE
(1R,5R,6R,7R,8S)-6,7,8-TRTIACETOXY-2-OXABICYCLO-[3.3.0]-OCTAN-3-ONE
(1R,5R,6S,7S,8S)-6,7,8-TRIACETOXY-2-OXABICYCLO-[3.3.0]-OCTAN-3-ONE
(3Z,6R*,7R*,9R*,10R*,12S*,13R*)-6:12-EPOXY-7,9,10,13-TETRAACETOXY-PENTADEC-3-EN-1-YNE
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.